Risk of developing cancer increased by prediabetes
the ONA take:
According to a new meta-analysis published in the journal Diabetologia, the journal of the European Association for the Study of Diabetes, the risk of developing cancer is increased by prediabetes. That risk differs depending on the type of cancer. In the study, researchers evaluated 16 studies from Asia, the United States, Europe, and Africa.
The researchers found that prediabetes is linked with a 15% elevated risk of developing cancer overall. They found that the results were similar across age, cancer endpoint, duration of follow-up, and ethnicity. In addition, acknowledging that obesity is also linked to the development of cancer, researchers performed a sensitivity analysis that adjusted for body mass index and found that prediabetes was linked with a 22% increased risk of cancer.
When analyzing specific cancers, researchers found that prediabetes was associated with an increased risk of breast, colorectum, endometrium, liver, pancreas, and stomach cancer, but not linked with bladder, kidney, lung, ovary, or prostate cancer.
Prediabetes refers to a hemoglobin A1C (Hgb A1C) between 5.7% and 6.4%, with diabetes beginning when a patient has a Hgb A1C of 6.5% or higher.
That risk differs depending on the type of cancer.
A meta-analysis comprising 16 studies and 891,426 participants from various regions of the world shows that prediabetes increases the risk of cancer by 15%, with differing risks depending on the type of cancer. The study, published in Diabetologia (the journal of the European Association for the Study of Diabetes) is by Professor Yuli Huang, The First People's Hospital of Shunde, Daliang Town, Shunde District, China, and colleagues.
Prediabetes is a general term that refers to an intermediate stage between normoglycaemia and overt diabetes mellitus. It includes individuals with impaired glucose tolerance (IGT), impaired fasting glucose (IFG) or a combination of the two. Results to date from prospective cohort studies investigating the link between prediabetes and risk of cancer are controversial.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Adherence to Tamoxifen, AIs Among Older Women is Low, Study Shows
- Replacing Neoadjuvant CRT with Multiagent Chemo Not Recommended for Rectal Cancer
- Study Identifies Factors Associated With Infection-related Complications in ALL
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- New Recommendations for Secondary Prevention of Cervical Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|